Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

Market Cap	2.47B
Revenue (ttm)	140.08M
Net Income (ttm)	-150.99M
Shares Out	109.93M
EPS (ttm)	-1.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	831,978
Average Volume	1,085,295
Open	22.70
Previous Close	22.60
Day's Range	22.40 - 22.80
52-Week Range	15.10 - 32.06
Beta	0.73
RSI	56.31
Earnings Date	Aug 29, 2025

About Jiangsu CoWin Biotech

Jiangsu CoWin Biotech Co., Ltd. engages in the research and development, production, and sale of biological products in China. The company provides molecular diagnostic raw material enzymes, nucleic acid collection and protection agents, nucleic acid extraction and purification kits, molecular diagnostic testing reagents, etc. It also offers medical device products, nucleic acid collection and protection, PCR, RT-PCR, and qPCR products, molecular diagnosis, isothermal amplification, nucleic acid mass spectrometry, next generation sequencing, nu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 833
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688426

Financial Performance

In 2024, Jiangsu CoWin Biotech's revenue was 125.88 million, a decrease of -26.54% compared to the previous year's 171.34 million. Losses were -157.21 million, 86.2% more than in 2023.